切换至 "中华医学电子期刊资源库"
高级检索
中华肝脏外科手术学电子杂志

中华肝脏外科手术学电子杂志 ›› 2018, Vol. 07 ›› Issue (01) : 53 -56. doi: 10.3877/cma.j.issn.2095-3232.2018.01.014

所属专题： 文献；

临床研究

增强CT及增强MRI图像融合技术在原发性肝癌治疗决策中的价值
唐建信1, 李星2, 邢艳芳3, 刘尚鑫4, 吴晨飞4, 江文钊4, 陈明4, 莫嘉辉4, 吴伟坤4, 吴祥元2, 姜楠1,†()   
  1. 1. 510630　广州，中山大学附属第三医院肝脏外科
    2. 510630　广州，中山大学附属第三医院肿瘤内科
    3. 510150　广州医科大学附属第三医院肾内科
    4. 510080　广州，中山大学中山医学院
  • 收稿日期:2017-10-17 出版日期:2018-02-10
  • 通信作者: 姜楠
  • 基金资助:
    国家自然科学基金(81572368); 广东省自然科学基金(2016A030313278，2016A030313302，2014A030313146); 广东省科技计划项目(2014A020212084)

Value of enhanced CT and enhanced MRI image fusion in treatment decisions for primary liver cancer

Jianxin Tang1, Xing Li2, Yanfang Xing3, Shangxin Liu4, Chenfei Wu4, Wenzhao Jiang4, Ming Chen4, Jiahui Mo4, Weikun Wu4, Xiangyuan Wu2, Nan Jiang1,†()   

  1. 1. Department of Hepatic Surgery, The third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    2. Department of Medical Oncology, The third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    3. Department of Nephrology, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China
    4. Sun Yat-sen University of Medical Sciences, Guangzhou 510080, China
  • Received:2017-10-17 Published:2018-02-10
  • Corresponding author: Nan Jiang
  • About author:
    Corresponding author: Jiang Nan, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

唐建信, 李星, 邢艳芳, 刘尚鑫, 吴晨飞, 江文钊, 陈明, 莫嘉辉, 吴伟坤, 吴祥元, 姜楠. 增强CT及增强MRI图像融合技术在原发性肝癌治疗决策中的价值[J/OL]. 中华肝脏外科手术学电子杂志, 2018, 07(01): 53-56.

Jianxin Tang, Xing Li, Yanfang Xing, Shangxin Liu, Chenfei Wu, Wenzhao Jiang, Ming Chen, Jiahui Mo, Weikun Wu, Xiangyuan Wu, Nan Jiang. Value of enhanced CT and enhanced MRI image fusion in treatment decisions for primary liver cancer[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(01): 53-56.

目的

探讨增强CT及增强MRI的图像融合技术在原发性肝癌（肝癌）治疗决策中的作用。

方法

回顾性分析2013年1月至2015年1月在中山大学附属第三医院接受诊治的55例肝癌患者临床资料。男42例，女13例；年龄18～84岁，中位年龄52岁。患者均签署知情同意书，符合医学伦理学规定。所有患者行增强CT扫描和钆塞酸二钠（Gd-EOB-DTPA）增强MRI扫描，采用基于有限元的柔性配准方法融合CT和MRI图像。由肝癌多学科会诊平台对患者的治疗决策进行讨论决定，每例患者进行2次讨论，首次基于增强CT图像，第2次基于融合图像。观察并分析治疗决策变更。

结果

基于增强CT图像的治疗决策包括根治性治疗8例、姑息性手术治疗35例、全身性药物治疗12例。基于融合图像的治疗决策包括根治性治疗4例、姑息性手术治疗36例、全身性药物治疗15例。基于融合图像的治疗决策较基于增强CT图像在根治性治疗、姑息性手术治疗、全身性药物治疗的转换率分别为50%（4/8）、3%（1/35）、25%（3/12）。

结论

增强CT和Gd-EOB-DTPA增强MRI的图像融合技术改变了部分肝癌患者的治疗决策，对优化治疗方案有一定的价值。

关键词: 肝肿瘤, 体层摄影术, 磁共振成像, 钆塞酸二钠, 图像融合
Objective

To explore the effect of enhanced CT and enhanced MRI image fusion technique in making treatment decisions for primary liver cancer (PLC).

Methods

Clinical data of55 patients with PLC who were treated in the Third Affiliated Hospital of Sun Yat-sen University between January 2013 and January 2015 were analyzed retrospectively. There were 42 males and 13 females, aged from 18-84 and with a median age of 52 years old. The informed consents of all patients were obtained and the local ethical committee approval was received. All the patients underwent enhanced CT and gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) enhanced MRI. CT and MRI images were fused by using flexible registration method based on finite element. Treatment decisions for these patients were discussed and made by HCC multidisciplinary consultation group. Discussion was conducted twice for each patient. The first discussion was based on enhanced CT images and the second was based on fused images. Changes of treatment decisions were observed and analyzed.

Results

Treatment decisions based on enhanced CT images included radical treatment in 8 cases, palliative surgical treatment in 35 cases and systemic medicine treatment in 12 cases. Treatment decisions based on fused images included radical treatment in 4 cases, palliative surgical treatment in 36 cases and systemic medicine treatment in 15 cases. Compared with those based on enhanced CT images, the conversion rate of radical treatment, palliative surgical treatment and systemic medicine treatment based on fused images was respectively 50%(4/8), 3%(1/35) and 25%(3/12).

Conclusions

Enhanced CT and Gd-EOB-DTPA enhanced MRI image fusion can change the treatment decisions for some patients with HCC, and it is of certain significance in optimizing the treatment protocols.

Key words: Liver neoplasms, Tomography, Magnetic resonance imaging, Gadolinium ethoxybenzyl diethyle-netriaminepentaacetic acid, Image fushion
图1 基于增强CT图像和融合图像的治疗决策差异
[1]
Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2012, 379(9822):1245-1255.
[2]
Schlachterman A, Craft WW Jr, Hilgenfeldt E, et al. Current and future treatments for hepatocellular carcinoma[J]. World J Gastroenterol, 2015, 21(28):8478-8491.
[3]
Chen HY, Hou YL, Ma XM, et al. CT and MRI in target delineation in primary hepatocellular carcinoma[J]. Cancer Radiother, 2013, 17(8):750-754.
[4]
Chou R, Cuevas C, Fu R, et al. Imaging techniques for the diagnosis of hepatocellular carcinoma: a systematic review and Meta-analysis[J]. Ann Intern Med, 2015, 162(10):697-711.
[5]
Powerski MJ, Scheurig-Münkler C, Hamm B, et al. Impaired hepatic Gd-EOB-DTPA enhancement after radioembolisation of liver malignancies[J]. J Med Imaging Radiat Oncol, 2014, 58(4):472-480.
[6]
Yamashita T, Kitao A, Matsui O, et al. Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma[J]. Hepatology, 2014, 60(5):1674-1685.
[7]
Ohama H, Imai Y, Nakashima O, et al. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI[J]. J Gastroenterol, 2014, 49(6):1081-1093.
[8]
Park H, Park JS, Seong JK, et al. Cortical surface registration using spherical thin-plate spline with sulcal lines and mean curvature as features[J]. J Neurosci Methods, 2012, 206(1):46-53.
[9]
朱鹏．《2016年美国国立综合癌症网络肝胆肿瘤临床实践指南(V2版)》更新要点及临床路径[J]．临床肝胆病杂志，2016，32(9):1644-1652.
[10]
Katsoulakis E, Riaz N, Cannon DM, et al. Image-guided radiation therapy for liver tumors: gastrointestinal histology matters[J]. Am J Clin Oncol, 2014, 37(6):561-567.
[11]
Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead[J]. Nat Rev Gastroenterol Hepatol, 2010 , 7(1):31-40.
[12]
李星，陈展洪，魏丽，等．不同分期系统对晚期肝癌预后预测价值的分析[J]．中华肿瘤防治杂志，2013，20(7):485-488.
[13]
Yoo SH, Choi JY, Jang JW, et al. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma[J]. Ann Surg Oncol, 2013, 20(9):2893-2900.
[14]
Böttcher J, Hansch A, Pfeil A, et al. Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation[J]. Eur J Radiol, 2013, 82(11):1860-1869.
[15]
Saito K, Moriyasu F, Sugimoto K, et al. Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule[J]. World J Gastroenterol, 2011, 17(30):3503-3509.
[16]
Park G, Kim YK, Kim CS, et al. Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine[J]. Br J Radiol, 2010, 83(996):1010-1016.
[17]
刘惠媛，陈志敏，曾健伟，等．415例原发性肝癌患者的临床特点分析[J]．新医学，2013，44(2):123-126.
[18]
Choi C, Choi GH, Kim TH, et al. Multimodality management for barcelona clinic liver cancer stage C hepatocellular carcinoma[J]. Liver Cancer, 2014, 3(3/4):405-416.
[19]
Saraswat VA, Pandey G, Shetty S. Treatment algorithms for managing hepatocellular carcinoma[J]. J Clin Exp Hepatol, 2014, 4 Suppl 3:S80-89.
[20]
Faria SC, Szklaruk J, Kaseb AO, et al. TNM/Okuda/Barcelona/UNOS/CLIP international multidisciplinary classification of hepatocellular carcinoma: concepts, perspectives, and radiologic implications[J]. Abdom Imaging, 2014, 39(5):1070-1087.
[1] 项文静, 徐燕, 茹彤, 郑明明, 顾燕, 戴晨燕, 朱湘玉, 严陈晨. 神经学超声检查在产前诊断胼胝体异常中的应用价值[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(05): 470-476.
[2] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[3] 郑永乐, 庞祖才, 陈家敏, 孙丙银. 骨碎补总黄酮抑制牵张成骨模型骨质疏松的作用研究[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 604-608.
[4] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[7] 刘明辉, 葛方明. MRI 对腹股沟疝修补术后患者早期并发症的评估价值研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 579-583.
[8] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[9] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[10] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[11] 林小勇, 张兰霞, 曾庆劲, 贺需旗, 谭雷, 郭光辉, 龙颖琳, 李凯, 吴宇轩. 负压抽吸活检针在肝困难病灶活检中的初步应用研究[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 694-698.
[12] 雷永琪, 刘新阳, 杨黎渝, 铁学宏, 俞星新, 耿志达, 刘雨, 陈政良, 惠鹏, 梁英健. 肝脏血管周上皮样细胞肿瘤合并贫血一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 710-718.
[13] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[14] 张立俊, 孙存杰, 胡春峰, 孟冲, 张辉. MSCT、DCE-MRI 评估术前胃癌TNM 分期的准确性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 519-523.
[15] 金安松, 邹玉松, 刘玖涛, 薛凤麟, 庞爱兰. 孤立性颅内浆细胞瘤一例及相关文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 495-500.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号